Cardiovascular access professional guiding payer and health system conversations with clinical evidence, patient outcome framing, and clear next steps for stakeholders. Supports access strategy by leading 15+ payer and benefits conversations per month, addressing formulary barriers, coverage questions, and launch readiness for cardiology and renal therapies. Draws on health system strategy and clinical credibility to support field reimbursement work across complex accounts.
Work History
Senior Cardiovascular Sales Specialist
4 Years 5 Months
AstraZeneca Pharmaceuticals | 05.2022 - Current
Grow Farxiga market share 35% within 12 months through territory analysis, targeted provider education, and account-specific growth initiatives.
Expand Lokelma volume more than 200% in under one year by identifying unmet treatment needs and strengthening stakeholder engagement.
Secure formulary access for Farxiga and Lokelma in key health systems by aligning clinical evidence, patient outcomes, and institutional treatment goals.
Lead the 2026 Baxfendy launch, building territory-specific implementation strategies and delivering clinical education to accelerate adoption.
Analyze prescribing trends, formulary barriers, and competitive dynamics to prioritize high-value accounts and build targeted business plans across Northeast Ohio and Northern West Virginia.
Nurse Practitioner, Heart Failure
2 Years 7 Months
Summa Health Medical Group – NEOCS | 10.2019 - 05.2022
Policy Associate at Australian Health Policy Collaboration - Victoria UniversityPolicy Associate at Australian Health Policy Collaboration - Victoria University